Intuitive Surgical Sits at the Center of a Demographic Tailwind That Won’t Fade Soon Life Science, Technology
Why Institutions Are Turning Bullish on Biohaven—and the Catalyst That Could Unlock Its Value Life Science
The Most Hated Trade on Wall Street Is Quietly Setting Up for a Massive Rotation Financial Service, Life Science
A Melanoma Drug Successfully Launched, Yet Iovance’s Stock Has Underperformed the Market for Three Years Life Science
How Should Investors Position Themselves in This Year’s S&P 500 “Dark Horses” Moderna and Target? Consumer Goods, Life Science
Seeking Opportunities Amid U.S. Stock Market Volatility, These Two Healthcare Stocks Are Both Cheap and High-Yielding Life Science
Faced with Aggression from Medtronic and Johnson & Johnson, How Does Intuitive Surgical Defend Its Monopoly? Life Science
